| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 08/28/2026 | ±6.3% | -10.3% | under-priced |
| 05/28/2026 | ±7.6% | +3.1% | over-priced |
| 12/03/2025 | ±4.6% | +7.9% | under-priced |
| 08/29/2025 | ±3.2% | -18.6% | under-priced |
| 05/30/2025 | ±5.2% | -5.5% | under-priced |
| 05/31/2024 | ±3.5% | -10.5% | under-priced |
| 12/01/2023 | ±2.3% | -5.3% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2027 | $0.33 | $2.7B | $308M |
| Q1 FY2027 | $0.04 | $2.4B | $35M |
| Q4 FY2026 | $0.46 | $2.2B | $396M |
| Q3 FY2026 | $2.20 | $2.1B | $1.9B |
Marvell Technology, Inc. Common Stock (MRVL) reports in 99 days, with the next report estimated for 12/19/2026. Across the last 7 reports, options priced an average ±4.7% earnings move while the stock actually moved 8.7% on average — the market has tended to under-price MRVL's earnings risk. Fundamentals into the print: EPS up 50.0% year-over-year, revenue up 36.5%. QuantLogix's live 5-factor engine currently reads MRVL as a buy at 71/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →